Latest Breakthroughs

SynGene Network Grant - Mechanism of Ultralong Replication-Transcription conflict to Pei-Chi Wei (2026)
Dr. Rolf M. Schwiete Foundation to Daniel Kirschenbaum (2026)
Wilhelm Sander Stiftung to Fung-Yi Cheung (2025)
Monika Kutzner Stiftung to Fung-Yi Cheung (2025)
FI EMS HARMONY - Hematological AI Resource for Morphological Network analysis to Mirco J. Friedrich (2025)
Core Investigator at Exzellenzcluster SynthImmune to Franziska Blaeschke (2025)
Center for Synthetic Genomics to Franziska Blaeschke (2025)
EU Horizon Grant EP PerMed HOPE to Ashok Kumar Jayavelu (2025)
DFG Grant FOR5086 Subproject P06 - Translation Control in Colorectal Cancer to Rene Jackstadt (2025)
DFG Grant FOR5086 Subproject CP2 - Data Integration and Analysis to Johannes Betge (2025)
DFG Grant FOR5086 Subproject P07 - Translation Control in Colorectal Cancer to Johannes Betge (2025)
DFG Grant SFB/CRC 1709 - Subproject B04 – Immunotherapy-induced plasticity to Franziska Blaeschke (2025)
DFG Grant CRC1709 Subproject B02 - Single Stem Cell Proteome to Ashok Kumar Jayavelu (2025)
DFG Grant CRC1709 Subproject A07 - Myeloid antigen plasticity to Mirco J. Friedrich (2025)
DFG Weave EU Framework Grant to Rene Jackstadt (2025)
DKH Grant Identify AML-recognizing T cells to  Mirco J. Friedrich (2025)
International Myeloma Society to Mirco J. Friedrich (2025)
Dr. Rolf M. Schwiete Foundation to Mirco J. Friedrich (2025)
Else Kröner Fresenius Foundation to Mirco J. Friedrich (2025)
José Carreras Leukemia Foundation Grant to Mirco J. Friedrich (2025)
Roche Network Grant imCORE to Mirco J. Friedrich (2025)
Emmy Noether Junior Group Network to Jens Puschhof (2025)
Emmy Noether Junior Group Network to Lena Kutscher (2025)
HFSP Early Career Research Grant to Franziska Blaeschke (2025)
ERC PoC Grant TI-uORFe to Fabricio Loayza-Puch (2025)
ERC PoC Grant REVIVE to Sun Chong (2025)
Dr. Rolf-Schwiete-Siftung to Franziska Blaeschke (2024)
ERC Consolidator Grant Unstable Genome to Aurelie Ernst (2024)
ERC Consolidator Grant FusionTRACE to Ana Banito (2024)
ERC Starting Grant METABAC to Jens Puschhof (2024)

Melanoma Research Alliance Young Investigator Award to Daniel Kirschenbaum (2026)
Hella Bühler Prize to Angelika Feldmann (2026)
Fourth prize in the Takeda Oncology Research Award to Rene-Filip Jackstadt (2026)
EACR Rising Star Award to Daniel Kirschenbaum (2026)
Henrik Kreibohm Award to Franziska Blaeschke (2025)
Forbes 30 under 30 – Science and Healthcare, Forbes Europe to Mirco J. Friedrich (2025)
Langener Wissenschaftspreis to Daniel Krischenbaum (2025)
Kind-Philipp-Forschungspreis 2025 to Mirco J. Friedrich (2025)
Metastasis Prize 2025 von der Beug Stiftung to Mirco J. Friedrich (2025)
Peter and Traudl Engelhorn Forschungspreis 2026 to Jens Puschhof (2025)
SWISS BRIDGE to Inmaculada Martíntez Reyes (2025)
Neuron Prize to Martina Benesova (2025)
Hella Bühler Prize to Moritz Mall (2025)
Erna-Brunner-Preis to Franziska Blaeschke (2025)
Forschungspreis der DAG-HSZT to Franziska Blaeschke (2024)
Johann-Georg-Zimmermann-Forschungspreis to Franziska Blaeschke (2024)
Kind-Philipp-Forschungspreispreis to Franziska Blaeschke (2024)
EMBO Young Investigator Program to Aurelie Ernst (2024)
EMBO Young Investigator Program to Ana Banito (2024)

Patent for Biomarkers of T cell reactivity by Mirco J. Friedrich (2025)
Clinical trial PERSIST-B7H6 for B cell malignancies by Mirco J. Friedrich (2025)
Clinical trial BilliCAN for Biliary Track Cancer intervention by Michael Dill (2025)
Patent for PSMA-targeting ligands for the diagnosis and treatment by Martina Benesova (2024)
FDA Approval for Lu-177-PSMA-617 (Pluvicto®) by Martina Benesova (2024)
Clinical trial EXTRA for Colorectal Cancer registry by Rene Jackstadt (2024)
Clinical trial TROPHIT1 phase II/III for Colorectal Cancer intervention by Rene Jackstadt (2024)
Clinical trial FLORA for HCC intervention by Michael Dill (2024)
 

Aurélie Ernst became a Division head since 01/2026
Fabricio Loayza-Puch became a Group Leader since 2025
Ana Banito became a Division head since 06/2025
Moritz Mall became a Division head since 06/2025
Titus Brinker became a Division head since 2024
Angela Gonçalves became a Professor in Computational Prevention and a Division head since 2024
 

Corazzi et al. Programed DNA breaks induce genome diversification (2026) Nature Communications
Siveke et al. Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma (2026) Nature Communications
Huang et al. IL41 ameliorates atopic dermatitis inflammation  (2025) Allergy
Veghini et al. MAPK Activity Defines Pancreatic Cancer Fibroblast subtypes (2024) Nature Communications
Kowar et al. found uORF Translation Boosts Tumor Antigen Presentation. (2025) Nature Communications
Aviles-Huerta et al. found Dual Ribosome Profiling Reveals Tumor Metabolic Limits. (2025) Nature Communications
Imle et al. Models High-Risk Sarcomas by Somatic Gene Delivery. (2025) Nature Communications
Eickelschulte et al. performed Digital Spatial Profiling Reveals phospho-JNK Biomarker. (2025) Front. Oncology
Egen et al. developed Hyperspectral Imaging Detects Renal Malperfusion. (2025) Eur. Urol. Open Sci.
Xiao et al. demonstreated Radiation Sensitization by MEK and PARP Inhibitors. (2025) Cell Rep. Medicine
Lim et al. found PROX1 Restrains Cell Fate Plasticity in Liver. (2025) Nature Genetics
Okonechnikov et al. showed Oncogene Aberrations Drive Medulloblastoma Progression. (2025) Nature
Palazzo et al. defined a p53–eIF5A Axis Controls Senescence Surveillance. (2024) Nature Communications
Baumgärtner et al. evaluated Medical Chatbot PROSCA for Patient Education. (2024) Eur. Urol. Open Sci.
Phillips et al. discovered Malformin C Sensitizes Glioblastoma Stem-Like Cells. (2024) Mol. Oncology
Alhalabi et al. demonstrated WEE1 Targeting Enhances Dasatinib in Proneural GBM. (2024) Cancer Letters
Corazzi and Ionasz et al. showed Replication Collision breaks DNA. (2024) Nature Communications
Mahara et al. found Transient promoter interactions modulate gene activation. (2024) Molecular Cell